POLYCYTHAEMIA Polycythaemia (or erythrocytosis) is defined as an increase
Personal Backgrounddl.abualisina.net/doc/CV/دکتر سید علی ملک حسینی.pdf · 14....
Transcript of Personal Backgrounddl.abualisina.net/doc/CV/دکتر سید علی ملک حسینی.pdf · 14....
CURRICULUM VITAE DR. SEYED ALI MALEK HOSSEINI
ABU – ALI SINA CHARITY HOSPITAL 1
Name: Seyed Ali Malek-Hosseini
Date of Birth: August 7, 1949
Place of Birth: Boyerahmad, Iran
Nationality: Iranian
Sex: Male
Marital Status: Married
Address: Shiraz Organ Transplant Center, Abu-Ali Sina Hospital, Shiraz University of
Medical Sciences, No 985, Boostan Blvd, Pasdaran Blvd, Sadra New City, Shiraz 71994-
67985, Iran
Tel: +98-71-3344-1701
Fax: +98-71-3647-4307
Professor of Surgery
Director, Shiraz Organ Transplant Center, Avicenna Hospital, Shiraz University
of Medical Sciences, Shiraz, Iran
Personal Background
Current Position
CURRICULUM VITAE DR. SEYED ALI MALEK HOSSEINI
ABU – ALI SINA CHARITY HOSPITAL 2
President, Iranian Society for Organ Transplantation
1974–81: Internship, Tehran University of Medical Sciences, Tehran, Iran
1982–86: General Surgery Resident, Shiraz University of Medical Sciences, Shiraz,
Iran
1987-88: Fellowship in kidney transplantation, Shahid Beheshti University of
Medical Sciences, Tehran, Iran
1990–92: Research fellow in liver transplantation, Pittsburgh, USA
2001: Research fellowship for six months, King’s College, London
1987–89: Director, Faghihi Hospital, Shiraz, Iran
1989 to date: Chief, Transplantation Section, Department of Surgery, Shiraz
University of Medical Sciences, Shiraz, Iran
1991 to date: Examiner, Iranian Board of General Surgery
1992–1994: Vice Chancellor, Shiraz University of Medical Sciences, Shiraz, Iran
1994: Chancellor, Shiraz University of Medical Sciences, Shiraz, Iran
2001 to date: Member, Editorial Board, Archive of Surgery
2005 to date: Permanent Member, Iranian Academy of Medical Sciences
2005 to date: Member, the specializing committee in clinical-surgical branch of Razi
Medical Festival
Educations
Positions
CURRICULUM VITAE DR. SEYED ALI MALEK HOSSEINI
ABU – ALI SINA CHARITY HOSPITAL 3
2010 to date: Founder and Editor, International Journal of Organ Transplantation
Medicine
2010: President Elect, Middle East Society for Organ Transplantation (MESOT)
2012: President, Middle East Society for Organ Transplantation (MESOT)
2014 to date: Member, High Council Committee for Organ Transplantation
2015 to date: President, Iranian Society for Organ Transplantation
1982–1986: General Surgery Resident, Shiraz University of Medical Sciences, Shiraz,
Iran
1987–1997: Assistant Professor of General Surgery, Department of Surgery, Shiraz
University of Medical Sciences, Shiraz, Iran
1987–1988: Fellowship in Vascular Surgery and Renal Transplantation, Shahid
Beheshti University of Medical Sciences, Tehran, Iran
1989–1992: Visiting Surgical Fellow in liver transplantation, Pittsburgh, USA
1997: Associate Professor of Surgery, Department of Surgery, Shiraz University of
Medical Sciences, Shiraz, Iran
2001: Research fellow for 6 months, King’s College, London
2001: Professor of Surgery, Department of Surgery, Shiraz University of Medical
Sciences, Shiraz, Iran.
Appointments
Surgical Activities
CURRICULUM VITAE DR. SEYED ALI MALEK HOSSEINI
ABU – ALI SINA CHARITY HOSPITAL 4
1987: Establishment of Organ Transplant Section, Shiraz University of Medical
Sciences, Shiraz, Iran
1992: The first kidney transplantation from a deceased donor
1993: The first liver transplantation in Iran
1998: The first partial liver transplantation in Iran
2002: The first liver transplantation from the right lobe (adult to adult)
More than 100 Awards and letters of commendation in Iran
2002: Memorable figure in medicine in Iran
2005: “Nevzat Bilgin Award” for the best poster presentation in the 8th Meeting of
the Turkish Transplantation Society, Ankara, Turkey
2011: The President’s Merit Badge (first class medal in science)
2012: MESOT Awards for establishment of the best deceased-donor transplant
center
2012: Fars Province memorable face
2013: Professor Yalda Scientific Medal
2013: Professor Haberal Scientific Medal for advancing organ donation in Turkey
2018: For the second time, MESOT Awards for establishment of the best deceased-
donor transplant center
1981: MD, Tehran University of Medical Sciences, Tehran, Iran
Awards
Qualifications
CURRICULUM VITAE DR. SEYED ALI MALEK HOSSEINI
ABU – ALI SINA CHARITY HOSPITAL 5
1986: Iranian Board of General Surgery
1988: Fellowship in Kidney Transplantation, Shahid Beheshti University of Medical
Sciences, Tehran, Iran
1992: Research fellow in liver transplantation, Pittsburgh, USA
Establishing the largest transplant center in the world with no previous example,
despite numerous obstacles, in a country where unrelated living donation and
organ trade had been prevailed. Relying only on deceased donors, we transplant
more than 500 liver transplants annually in the center. We crossed the world
record and transplanted 638 liver transplants in the Center in 2017.
Establishing a twin charity hospital: the 700-bed Avicenna Transplant Center
including a large polyclinic and an 80-bed hemodialysis center, and a nearby
1000-bed hospital to care for patients diagnosed with cancer.
Pioneer of deceased donor organ donation in Iran
Founder of deceased donor organ donation in Iran
Establishment of the most active deceased donor program in the Middle East and
Asia
Founder of Transplant Coordinator Network across Iran
The most active person fighting against living unrelated renal transplantation
and organ selling in Iran
More than three decades activities to establish deceased donor program in Iran
Training of more than 50 transplant fellows for Iran and Middle East Society for
Organ Transplantation (MESOT) states
Founder of charity societies for kidney and liver disease in Fars province,
southern Iran
Founder of a charity for cancer in South of Iran
Achievements
CURRICULUM VITAE DR. SEYED ALI MALEK HOSSEINI
ABU – ALI SINA CHARITY HOSPITAL 6
1. Ahmad E, Malek Hosseini SA, Nezakatgoo N, et al. A report of 26 cases of renal
transplantation in children. Transplant Proc 1995;27:2570.
2. Ahmad E, Malek Hosseini SA, Salahi H, et al. Experience with 300 renal
transplants in Shiraz, Iran. Transplant Proc 1995;27:2767.
3. Malek Hosseini SA, Javid R, Salahi H, et al. A case report of Kala-Azar in a kidney
transplant patient. Transplant Proc 1995;27:2715.
4. Malek Hosseini SA, Lahsaee M, Zare S, et al. Report of the first liver transplants in
Iran. Transplant Proc 1995;27:2618.
5. Malek Hosseini SA, Salahi H, Nezakatgoo N, et al. First report of nine consecutive
multiorgan cadaver donor transplants in Iran. Transplant Proc 1995;27:2770.
6. Salahi H, Malek Hosseini SA, Ahmad E, et al. Mannitol infusion and decreased
incidence of allograft acute renal failure. Transplant Proc 1995;27:2569.
7. Ghahramani NL, Malek-Hosseini SA, Rais-Jalali GA, et al. Factors relating to
posttransplant erythrocytosis in renal allograft recipients. Transplant Proc
1998;30:828-9.
8. Malek-Hosseini SA, Ghahramani N, Behzadi S, et al. Incidence of posttransplant
hypertension among renal allograft recipients. Transplant Proc 1998;30:775-6.
9. Salahi H, Ghahramani N, Malek-Hosseini SA, et al. Religious sanctions regarding
cadaveric organ transplantation in Iran. Transplant Proc 1998;30:769-70.
10. Ahmad E, Ghahramani N, Malek-Hosseini SA, et al. Transplant outcome as related
to prolonged chronic dialysis versus short-term pretransplantation dialysis.
Transplant Proc 1999; 31:3135.
11. Ahmad E, Malek-Hosseini SA, Salahi H, et al. Posttransplant urinary
complications; a thing of the past after insertion of inexpensive ureteral stent.
Transplant Proc 1999;31:3210.
12. Ghahramani N, Behzadi A, Gholami S, et al. Postrenal transplant improvement of
sexual function. Transplant Proc 1999; 31:3144.
13. Ghahramani N, Behzadi S, Malek-Hosseini SA, et al. Occurrence of hypertension
Publications
CURRICULUM VITAE DR. SEYED ALI MALEK HOSSEINI
ABU – ALI SINA CHARITY HOSPITAL 7
and proteinuria among kidney donors in Shiraz Nemazee Hospital. Transplant Proc
1999; 31:3139.
14. Javid R, Ghahramani N, Malek-Hosseini SA, et al. Management of posttransplant
erythrocytosis with enalapril. Transplant Proc 1999;31:3226.
15. Nezakatgoo N, Malek-Hosseini SA, Salahi H, et al. Lessons learned from the first
successful living-related liver transplantation. Transplant Proc 1999;31:3171.
16. Salahi H, Malek-Hosseini SA, Ghahramani N, et al. Occurrence of renal graft
failure among 386 patients transplanted in Shiraz Nemazee Hospital 1989-1996.
Transplant Proc 1999;31:3110-1.
17. Ahmad E, Salahi H, Ghahramani N, et al. Simultaneous previously failed graft
nephrectomy and the use of same vessels for vascular anastomosis in second renal
transplantation. Transplant Proc 2001;33:2669.
18. Ghahramani N, Salahi H, Malek-Hosseini SA, et al. Transplant outcome in patients
with non-O blood groups who received kidneys from O blood group donors.
Transplant Proc 2001;33:2841.
19. Salahi H, Ghahramani N, Malek-Hosseini SA, et al. Effect of donor nephrectomy
on renal function and blood pressure. Transplant Proc 2001;33:2654.
20. Salahi H, Malek-Hosseini SA, Ghahramani N, et al. The efficacy of ureteral stents
in prevention of urological complications in renal transplantation. Transplant Proc
2001;33:2668.
21. Malek-hosseini SA, Lahsaee M, Salahi H, et al. Living related liver transplantation
in children: the Iranian experience. Transplant Proc 2003;35:377-8.
22. Malek-hosseini SA, Salahi H, Lahsaee M, et al. Initial experience with liver
transplantation in Iran. Transplant Proc 2003;35:375-6.
23. Mosallaci M, Ghahramani N, Malek-hosseini SA, Tavakoli AR. Renal
transplantation in diabetic nephropathy. Transplant Proc 2003;35:149-51.
24. Farshad S, Alborzi A, Malek Hosseini SA, et al. Identification of Helicobacter pylori
DNA in Iranian patients with gallstones. Epidemiol Infect 2004;132:1185-9.
25. Behzad-Behbahani A, Mojiri A, Tabei SZ, et al. Outcome of hepatitis B and C virus
infection on graft function after renal transplantation. Transplant Proc 2005;37:3045-
7.
26. Malek-Hosseini SA, Mehdizadeh AR, Salahi H, et al. Results of liver
transplantation: analysis of 140 cases at a single center. Transplant Proc
2005;37:3157-8.
27. Raiss-Jalali GA, Mehdizadeh AR, Razmkon A, et al. Effect of body mass index at
time of transplantation and weight gain after transplantation on allograft function
in kidney transplant recipients in Shiraz. Transplant Proc 2005;37:2998-3000.
CURRICULUM VITAE DR. SEYED ALI MALEK HOSSEINI
ABU – ALI SINA CHARITY HOSPITAL 8
28. Roozbeh J, Mehdizadeh AR, Razmkon A, Malek-Hosseini SA. Incidence of
posttransplantation diabetes mellitus in kidney transplantation: a single-center
experience. Transplant Proc 2005;37:3095-7.
29. Salahi H, Razmkon A, Mehdizadeh AR, et al. Biliary tract complications after liver
transplantation in a single center. Transplant Proc 2005;37:3177-8.
30. Geramizadeh B, Roozbeh J, Malek-Hosseini SA, et al. Urine cytology as a useful
screening method for polyoma virus nephropathy in renal transplant patients: a
single-center experience. Transplant Proc 2006;38:2923-5.
31. Malek-Hosseini SA, Salahi H, Bahador A, et al. Pediatric liver transplantation in
the Shiraz Transplant Center. Transplant Proc 2006;38:594-5.
32. Ostovan MA, Fazelzadeh A, Mehdizadeh AR, et al. How to decrease
cardiovascular mortality in renal transplant recipients. Transplant Proc
2006;38:2887-92.
33. Roozbeh J, Mehdizadeh AR, Izadfar MA, et al. Comparison of spousal with other
donor groups: Study of a single center. Transplant Proc 2006;38:562-3.
34. Salahi H, Fazelzadeh A, Mehdizadeh A, et al. Complications of arteriovenous
fistula in dialysis patients. Transplant Proc 2006;38:1261-4.
35. Salahi H, Salehipour M, Bahador A, et al. Transplantation of a lump or cake
kidney: a case report. Saudi J Kidney Dis Transpl 2006;17:577-8.
36. Bahador A, Yazdani M, Gholami S, et al. Foundation of local network for
increasing organ donation in southern Iran. Transplant Proc 2007;39:801-2.
37. Davari HR, Malek-Hosseini SA, Salahi H, et al. Management of infrarenal
duplicated inferior vena cava during living related kidney transplantation. Transpl
Int 2007;20:478-9.
38. Dehghani SM, Bahador A, Gholami S, et al. Pediatric liver transplantation in Iran:
evaluation of the first 50 cases. Pediatr Transplant 2007;11:256-60.
39. Dehghani SM, Gholami S, Bahador A, et al. Comparison of Child-Turcotte-Pugh
and pediatric end-stage liver disease scoring systems to predict morbidity and
mortality of children awaiting liver transplantation. Transplant Proc 2007;39:3175-7.
40. Dehghani SM, Gholami S, Bahador A, et al. Morbidity and mortality of children
with chronic liver diseases who were listed for liver transplantation in Iran. Pediatr
Transplant 2007;11:21-3.
41. Dehghani SM, Taghavi SA, Eshraghian A, et al. Hyperlipidemia in Iranian liver
transplant recipients: prevalence and risk factors. J Gastroenterol 2007;42:769-74.
42. Dinckan A, Tekin A, Turkyilmaz S, et al. Horseshoe kidney for transplant: report of
3 cases. Exp Clin Transplant 2007;5:716-9.
CURRICULUM VITAE DR. SEYED ALI MALEK HOSSEINI
ABU – ALI SINA CHARITY HOSPITAL 9
43. Khosravi MB, Jalaeian H, Lahsaee M, et al. The effect of clamping of inferior vena
cava and portal vein on urine output during liver transplantation. Transplant Proc
2007;39:1197-8.
44. Kumar PV, Monabati A, Raseki AR, et al. Splenic lesions: FNA findings in 48 cases.
Cytopathology 2007;18:151-6.
45. Nikeghbalian S, Kazemi K, Davari HR, et al. Early hepatic artery thrombosis after
liver transplantation: diagnosis and treatment. Transplant Proc 2007;39:1195-6.
46. Nikeghbalian S, Kazemi K, Salahi H, et al. Transplantation of a cadaveric liver
allograft with right lobe cavernous hemangioma, without back-table resection: a
case report. Transplant Proc 2007;39:1691-2.
47. Nikeghbalian S, Nejatollahi SM, Salahi H, et al. Does donor's fatty liver change
impact on early mortality and outcome of liver transplantation. Transplant Proc
2007;39:1181-3.
48. Rais-Jalali GA, Sagheb MM, Daniali F, et al. Acute renal failure in the first 100
orthotopic liver transplant patients in Southern Iran. Exp Clin Transplant
2007;5:710-2.
49. Salahi H, Jalaeian H, Nikeghbalian S, et al. The comparison of clinical and
biochemical parameters among 1200 alive and dead renal transplant recipients.
Saudi J Kidney Dis Transpl 2007;18:439-42.
50. Salahi H, Nikeghbalian S, Shamsaee AR, et al. Comparison of early outcome and
histologic findings of enteric drainage with bladder drainage in pancreas
transplantation of dogs. Transplant Proc 2007;39:1255-6.
51. Salehipour M, Bahador A, Salahi H, et al. Transplantation of a horseshoe kidney.
Arch Iran Med 2007;10:239-41.
52. Salehipour M, Jalaeian H, Salahi H, et al. Are large nonfunctional kidneys risk
factors for posttransplantation urinary tract infection in patients with end-stage
renal disease due to autosomal dominant polycystic kidney disease? Transplant
Proc 2007;39:887-8.
53. Dehghani SM, Derakhshan A, Taghavi SA, et al. Prevalence and risk factors of
renal dysfunction after liver transplant: a single-center experience. Exp Clin
Transplant 2008;6:25-9.
54. Dehghani SM, Nikeghbalian S, Kazemi K, et al. Outcome of bowel perforation after
pediatric liver transplantation. Pediatr Transplant 2008;12:146-9.
55. Dehghani SM, Taghavi SA, Imanieh MH, et al. Diabetes mellitus after liver
transplantation in Iranian patients. Indian J Gastroenterol 2008;27:83-4.
56. Geramizadeh B, Malek-Hosseini SA, Salahi H, et al. Liver failure and the need for
transplantation in three patients with hepatoportal sclerosis. Transplant Proc
CURRICULUM VITAE DR. SEYED ALI MALEK HOSSEINI
ABU – ALI SINA CHARITY HOSPITAL 10
2008;40:3526-8.
57. Kazemi K, Geramizadeh B, Nikeghbalian S, et al. Effect of D-penicillamine on liver
fibrosis and inflammation in Wilson disease. Exp Clin Transplant 2008;6:261-3.
58. Mokarram P, Naghibalhossaini F, Saberi Firoozi M, et al.
Methylenetetrahydrofolate reductase C677T genotype affects promoter
methylation of tumor-specific genes in sporadic colorectal cancer through an
interaction with folate/vitamin B12 status. World J Gastroenterol 2008;14:3662-71.
59. Nikeghbalian S, Malek-Hosseini SA, Salahi H, et al. Pancreas transplantation in
shiraz organ transplant center; the first Iranian experience. Arch Iran Med
2008;11:490-6.
60. Rasekhi AR, Nabavizadeh SA, Malek-Hosseini SA, et al. Percutaneous transhepatic
venous angioplasty and stenting in a 9-month-old patient with hepatic vein
obstruction after partial liver transplantation. Cardiovasc Intervent Radiol
2008;31:1034-7.
61. Roozbeh J, Jalaeian H, Banihashemi MA, et al. The socioeconomic status of 100
renal transplant recipients in Shiraz. Saudi J Kidney Dis Transpl 2008;19:286-90.
62. Roozbeh J, Razmkon AR, Jalaeian H, et al. Outcome of kidney transplantation in
patients with polycystic kidney disease: a single center study. Saudi J Kidney Dis
Transpl 2008;19:72-5.
63. Salehipour M, Bahador A, Jalaeian H, et al. Comparison of right and left grafts in
renal transplantation. Saudi J Kidney Dis Transpl 2008;19:222-6.
64. Soroush AR, Ghahri-Saremi S, Rambod M, et al. Pattern of injury in Shiraz. Chin J
Traumatol 2008;11:8-12.
65. Amirghofran AA, Emaminia A, Rayatpisheh S, et al. Intracardiac invasive
thymoma presenting as superior vena cava syndrome. Ann Thorac Surg
2009;87:1616-8.
66. Bahador A, Salahi H, Nikeghbalian S, et al. Pediatric liver transplantation in Iran: a
9-year experience. Transplant Proc 2009;41:2864-7.
67. Bahador A, Salahi H, Nikeghbalian S, et al. Split liver transplantation in Shiraz
Transplant Center. Transplant Proc 2009;41:2872-4.
68. Dehghani SM, Eshraghian A, Bahador A, et al. De novo inflammatory bowel
disease after pediatric orthotopic liver transplant: a case report. Exp Clin Transplant
2009;7:145-8.
69. Dehghani SM, Nikeghbalian S, Eshraghian A, et al. New-onset diabetes mellitus
presenting with diabetic ketoacidosis after pediatric liver transplantation. Pediatr
Transplant 2009;13:536-9.
70. Dehghani SM, Shakiba MA, Ziaeyan M, et al. Vaccination status in pediatric liver
CURRICULUM VITAE DR. SEYED ALI MALEK HOSSEINI
ABU – ALI SINA CHARITY HOSPITAL 11
transplant candidates. Pediatr Transplant 2009;13:820-2.
71. Geramizadeh B, Azarpira N, Ayatollahi M, et al. Value of serum cystatin C as a
marker of renal function in the early post kidney transplant period. Saudi J Kidney
Dis Transpl 2009;20:1015-7.
72. Hashemi SB, Shishegar M, Nikeghbalian S, et al. Endogenous Aspergillus
endophthalmitis occurring after liver transplantation: a case report. Transplant Proc
2009;41:2933-5.
73. Imanieh MH, Erjaee A, Dehghani SM, et al. Early postoperative complications of
pediatric liver transplantation. Indian Pediatr 2009;46:1088-90.
74. Kakaei F, Nikeghbalian S, Kazemi K, et al. Liver transplantation for homozygous
familial hypercholesterolemia: two case reports. Transplant Proc 2009;41:2939-41.
75. Nikeghbalian S, Bahador A, Salahi H, et al. Non-marginal donor C-loop ulcers as a
cause of gastrointestinal bleeding after pancreas transplantation: three case
reports. Transplant Proc 2009;41:2930-2.
76. Nikeghbalian S, Dehghani M, Salahi H, et al. Effects of surgical technique on
postoperative renal function after orthotopic liver transplant. Exp Clin Transplant
2009;7:25-7.
77. Nikeghbalian S, Kazemi K, Salehipour M, et al. Transperitoneal laparoscopic living
donor nephrectomy: 2 years' experience. Transplant Proc 2009;41:2729-30.
78. Nikeghbalian S, Nejatollahi SM, Salahi H, et al. Experience of living donor liver
transplantation in Iran: a single-center report. Transplant Proc 2009;41:2868-71.
79. Nikeghbalian S, Salahi R, Salahi H, et al. Hepatic abscesses after liver transplant:
1997-2008. Exp Clin Transplant 2009;7:256-60.
80. Omidvari S, Malek-Hosseini SA, Attaran Y, et al. Photoclinic. Primary
adenocarcinoma of the appendix presenting as a buttock mass. Arch Iran Med
2009;12:82, 5-6.
81. Salehipour M, Salahi H, Jalaeian H, et al. Vascular complications following 1500
consecutive living and cadaveric donor renal transplantations: a single center
study. Saudi J Kidney Dis Transpl 2009;20:570-2.
82. Dehghani SM, Haghighat M, Imanieh MH, et al. Tacrolimus related hypertrophic
cardiomyopathy in liver transplant recipients. Arch Iran Med 2010;13:116-9.
83. Dehghani SM, Honar N, Inaloo S, et al. Neuromuscular complication after liver
transplant in children: a single-center experience. Exp Clin Transplant 2010;8:9-13.
84. Geramizadeh B, Bahador A, Foroutan HR, et al. Pathology of pediatric liver
tumors, a single center experience from south of Iran. Indian J Pathol Microbiol
2010;53:422-6.
CURRICULUM VITAE DR. SEYED ALI MALEK HOSSEINI
ABU – ALI SINA CHARITY HOSPITAL 12
85. Geramizadeh B, Keramati P, Bahador A, et al. Congenital hepatic fibrosis and need
for liver transplantation. Int J Organ Transplant Med 2010;1:98-100.
86. Geramizadeh B, Malek-Hosseini SA, Bahador A, et al. Post-transplantation
lymphoproliferative disorder after liver transplantation: report of 5 cases among
more than 550 liver transplants in Iran. Arch Iran Med 2010;13:417-9.
87. Hashiani AA, Rajaeefard A, Hasanzadeh J, et al. Ten-year graft survival of
deceased-donor kidney transplantation: a single-center experience. Ren Fail
2010;32:440-7.
88. Kakaei F, Nikeghbalian S, Salahi H, et al. Liver transplantation in the presence of
old portal vein thrombosis. Int J Organ Transplant Med 2010;1:44-8.
89. Khosravi MB, Sattari H, Ghaffaripour S, et al. Post-reperfusion Syndrome and
Outcome Variables after Orthotopic Liver Transplantation. Int J Organ Transplant
Med 2010;1:115-20.
90. Malek-Hosseini SA, Baezzat SR, Shamsaie A, et al. Huge immature teratoma of the
liver in an adult: a case report and review of the literature. Clin J Gastroenterol
2010;3:332-6.
91. Nikeghalian S, Davari HR, Kakaei F, et al. The first modified multivisceral
transplantation in the middle East: a major advance in transplantation surgery in
shiraz transplant center. Int J Organ Transplant Med 2010;1:189-92.
92. Nikeghbalian S, Hosseini SM, Bananzadeh AM, et al. Using inverted autogenous
veins to substitute arteries in a canine model. J Emerg Trauma Shock 2010;3:238-42.
93. Roozbeh J, Sattarinezhad A, Afshariani R, et al. The effect of simvastatin on
lowering panel reactive antibody titer in sensitized dialysis patients: a randomized
placebo controlled clinical trial. Int J Organ Transplant Med 2010;1:85-90.
94. Salehipour M, Monabbati A, Salahi H, et al. Protective effect of parenteral vitamin
E on ischemia-reperfusion injury of rabbit kidney. Urology 2010;75:858-61.
95. Salehipour M, Roozbeh J, Rasekhi AR, et al. Emphysematous pyelonephritis in a
transplant kidney. Int J Organ Transplant Med 2010;1:49-51.
96. Salehipour M, Salahi H, Fathikalajahi A, et al. Is perioperative intravesically
applied antibiotic solution effective in the prophylaxis of urinary tract infections
after renal transplantation? Urol Int 2010;85:66-9.
97. Almasi-Hashiani A, Rajaeefard AR, Hassanzade J, et al. Graft survival rate of renal
transplantation: a single center experience, (1999-2009). Iran Red Crescent Med J
2011;13:392-7.
98. Azarpira N, Geramizadeh B, Nikeghbalian S, et al. Endothelial Nitric Oxide
Synthase Gene T-786C Polymorphism in Renal Transplant Recipients. Int J Organ
Transplant Med 2011;2:87-92.
CURRICULUM VITAE DR. SEYED ALI MALEK HOSSEINI
ABU – ALI SINA CHARITY HOSPITAL 13
99. Davari HR, Malek-Hosseini SA, Salahi H, et al. Liver transplantation and aortic
valve replacement. Int J Organ Transplant Med 2011;2:32-6.
100. Dehghani SM, Aleyasin S, Honar N, et al. Pulmonary evaluation in pediatric liver
transplant candidates. Indian J Pediatr 2011;78:171-5.
101. Dehghani SM, Gholami S, Bahador A, et al. Causes of organ donation refusal in
southern Iran. Transplant Proc 2011;43:410-1.
102. Derakhshan N, Derakhshan D, Derakhshan A, et al. Hyperlipidemia in children
with normal allograft function. Saudi J Kidney Dis Transpl 2011;22:339-40.
103. Ebadi M, Yaghobi R, Geramizadeh B, et al. Prevalence of HCV and HGV infections
in Iranian liver transplant recipients. Transplant Proc 2011;43:618-20.
104. Fallahzadeh MK, Fallahzadeh MH, Derakhshan A, et al. Urinary tract infection
after kidney transplantation in children and adolescents. Iran J Kidney Dis
2011;5:416-9.
105. Geramizadeh B, Attaran Y, Malek-Hosseini SA, et al. Photoclinic. Alveolar hydatid
cyst of the liver. Arch Iran Med 2011;14:211-2.
106. Geramizadeh B, Nikeghbalian S, Shamsaifar A, et al. Primary glomus tumor of the
liver: a rare case report and review of the literature. Indian J Pathol Microbiol
2011;54:584-7.
107. Geramizadeh B, Safari A, Bahador A, et al. Hepatic angiosarcoma of childhood: a
case report and review of literature. J Pediatr Surg 2011;46:e9-11.
108. Honar N, Imanieh MH, Dehghani SM, et al. Evaluation of cytomegalovirus
infection after six months of liver transplantation in children in shiraz, southern
iran. Int J Organ Transplant Med 2011;2:20-4.
109. Honar N, Imanieh MH, Haghighat M, et al. Evaluation of Candida infection after
six months of transplantation in pediatric liver recipients in iran. Int J Organ
Transplant Med 2011;2:105-7.
110. Malek-Hosseini SA, Vessal K. Euthanasia. Arch Iran Med 2011;14:224; author reply
111. Moini M, Hoseini-Asl MK, Taghavi SA, et al. Hyponatremia a valuable predictor of
early mortality in patients with cirrhosis listed for liver transplantation. Clin
Transplant 2011;25:638-45.
112. Nemayandeh M, Yaghobi R, Geramizadeh B, et al. Hematologic and biochemical
indices and viral hepatitis in liver transplant patients. Transplant Proc 2011;43:612-
4.
113. Nikeghbalian S, Pournasr B, Aghdami N, et al. Autologous transplantation of bone
marrow-derived mononuclear and CD133(+) cells in patients with decompensated
cirrhosis. Arch Iran Med 2011;14:12-7.
CURRICULUM VITAE DR. SEYED ALI MALEK HOSSEINI
ABU – ALI SINA CHARITY HOSPITAL 14
114. Sagheb MM, Sharifian M, Ahmadi S, et al. Comparison of immediate renal
dysfunction in split and partial liver transplantation versus full size liver
transplantation in Shiraz transplant centre. Ann Transplant 2011;16:36-42.
115. Salehipour M, Roozbeh J, Eshraghian A, et al. Postrenal transplant urinary leakage
caused by segmental infarction of a renal allograft treated by partial nephrectomy.
Exp Clin Transplant 2011;9:153-5.
116. Sarvari J, Mojtahedi Z, Kuramitsu Y, et al. Differential expression of haptoglobin
isoforms in chronic active hepatitis, cirrhosis and HCC related to HBV infection.
Oncol Lett 2011;2:871-7.
117. Yaghobi R, Geramizadeh B, Zamani S, et al. The molecular and antigenic tissue
impact of viral infections on liver transplant patients with neonatal hepatitis. Int J
Organ Transplant Med 2011;2:108-15.
118. Zahmatkeshan M, Geramizadeh B, Eshraghian A, et al. De novo fatty liver due to
vascular complications after liver transplantation. Transplant Proc 2011;43:615-7.
119. Zali N, Mohebbi SR, Esteghamat S, et al. Prevalence of ATP7B Gene Mutations in
Iranian Patients With Wilson Disease. Hepat Mon 2011;11:890-4.
120. Dehghani M, Poorseidi B, Sattari H, et al. Two-year experience of orthotopic liver
transplantation in afzalipoor hospital, kerman, southeastern iran. Int J Organ
Transplant Med 2012;3:120-3.
121. Dehghani SM, Imanieh MH, Honar N, et al. Evaluation of quality of life in children
six months after liver transplantation. Middle East J Dig Dis 2012;4:158-62.
122. Dehghani SM, Karamifar H, Hamzavi SS, et al. Serum insulinlike growth factor-1
and its binding protein-3 levels in children with cirrhosis waiting for a liver
transplant. Exp Clin Transplant 2012;10:252-7.
123. Geramizadeh B, Foroughi R, Keshtkar-Jahromi M, et al. Gastrointestinal
basidiobolomycosis, an emerging infection in the immunocompetent host: a report
of 14 patients. J Med Microbiol 2012;61:1770-4.
124. Mahmoudi H, Jafari P, Alizadeh-Naini M, et al. Validity and reliability of Persian
version of Chronic Liver Disease Questionnaire (CLDQ). Qual Life Res
2012;21:1479-85.
125. Roozbeh J, Eshraghian A, Geramizadeh B, et al. A rare incidence of
angiomyolipoma after kidney transplantation. Iran J Kidney Dis 2012;6:311-3.
126. Salehipour M, Bahador A, Nikeghbalian S, et al. En-bloc Transplantation: an
Eligible Technique for Unilateral Dual Kidney Transplantation. Int J Organ
Transplant Med 2012;3:111-4.
127. Azarpira N, Nikeghbalian S, Kazemi K, et al. Association of Increased Plasma
Interleukin-6 and TNF-alpha Levels in Donors with the Complication Rates in
CURRICULUM VITAE DR. SEYED ALI MALEK HOSSEINI
ABU – ALI SINA CHARITY HOSPITAL 15
Liver Transplant Recipients. Int J Organ Transplant Med 2013;4:9-14.
128. Dehghani SM, Bahador A, Nikeghbalian S, et al. Liver transplant in a case of
arthrogryposis-renal tubular dysfunction-cholestasis syndrome with severe
intractable pruritus. Exp Clin Transplant 2013;11:290-2.
129. Dehghani SM, Taghavi SA, Geramizadeh B, et al. Hepatitis B recurrence after liver
transplantation: a single center experiences and review the literature. Hepat Mon
2013;13:e6609.
130. Geramizadeh B, Motevalli D, Nikeghbalian S, Malek Hosseini SA. Histopathology
of post-transplant liver biopsies, the first report from iran. Hepat Mon
2013;13:e9389.
131. Haseli N, Hassanzadeh J, Dehghani SM, et al. Long-term survival and its related
factors in pediatric liver transplant recipients of shiraz transplant center, shiraz,
iran in 2012. Hepat Mon 2013;13:e10257.
132. Khosravi MB, Milani S, Ghaffaripour S, et al. Very High Dose Epinephrine for the
Treatment of Vasoplegic Syndrome during Liver Transplantation. Int J Organ
Transplant Med 2013;4:32-4.
133. Lankarani KB, Eshraghian K, Malek-Hosseini SA, et al. Outcomes of liver
transplantation for patients with acute liver failure. Arch Iran Med 2013;16:64-7.
134. Azarpira N, Aghdai MH, Nikeghbalian S, et al. Human islet cell isolation: the
initial step in an islet transplanting program in Shiraz, Southern Iran. Exp Clin
Transplant 2014;12:139-42.
135. Dehghani SM, Basiratnia M, Derakhshan A, et al. Urinary tract infection in children
with cirrhosis waiting for liver transplantation. Saudi J Kidney Dis Transpl
2014;25:876-80.
136. Dehghani SM, Shakiba MA, Ziaeyan M, et al. Evaluation of immunity status to
routine vaccination in pediatric liver transplant candidates. Turk J Gastroenterol
2014;25 Suppl 1:26-31.
137. Firoozifar M, Khosravi MB, Ghafari S, et al. Shiraz guideline for the management
of patients with brain death. Int J Organ Transplant Med 2014;5:34-7.
138. Geramizadeh B, Gity R, Bahraini A, Malek-Hosseini SA. Synchronous
hepatocellular carcinoma and cholangiocarcinoma in a patient transplanted for
cryptogenic cirrhosis. Int J Organ Transplant Med 2014;5:125-8.
139. Lankarani KB, Eshraghian A, Nikeghbalian S, et al. New onset diabetes and
impaired fasting glucose after liver transplant: risk analysis and the impact of
tacrolimus dose. Exp Clin Transplant 2014;12:46-51.
140. Lankarani KB, Nikeghbalian S, Janghorban P, Malek-Hosseini SA. Response to:
Comment on: New-onset diabetes and impaired fasting glucose after liver
CURRICULUM VITAE DR. SEYED ALI MALEK HOSSEINI
ABU – ALI SINA CHARITY HOSPITAL 16
transplant: risk analysis and the impact of tacrolimus dose. Exp Clin Transplant
2014;12:86.
141. Lankarani KB, Talebzadeh M, Eshraghian A, Malek-Hosseini SA. Granulocyte
colony stimulating factor adjuvant role on the immunological response to hepatitis
B vaccine in patients with cirrhosis: a double blind randomized placebo controlled
trial. Hepat Mon 2014;14:e15447.
142. Nikeghbalian S, Aliakbarian M, Kazemi K, et al. Ex-vivo Resection and Small-
Bowel Auto-transplantation for the Treatment of Tumors at the Root of the
Mesentery. Int J Organ Transplant Med 2014;5:120-4.
143. Sahmeddini MA, Janatmakan F, Khosravi MB, et al. Restricted Crystalloid Fluid
Therapy during Orthotopic Liver Transplant Surgery and its Effect on Respiratory
and Renal Insufficiency in the Early Post-operative Period: A Randomized Clinical
Trial. Int J Organ Transplant Med 2014;5:113-9.
144. Sahraian A, Sharifian M, Geramizadeh B, Malek-Hosseini SA. Psychiatric
Disorders and their Association with Liver Transplant Outcome In Iran. Int J
Organ Transplant Med 2014;5:179-80.
145. Toosi M, Moaddabshoar L, Malek-Hosseini SA, et al. Rectal cancer in pregnancy: a
diagnostic and therapeutic challenge. J Egypt Natl Canc Inst 2014;26:175-9.
146. Afshari A, Yaghobi R, Karimi MH, et al. IL-17 mRNA expression and
cytomegalovirus infection in liver transplant patients. Exp Clin Transplant 2015;13
Suppl 1:83-9.
147. Bagheri Lankarani K, Homayon K, Motevalli D, et al. Risk Factors for Portal Vein
Thrombosis in Patients With Cirrhosis Awaiting Liver Transplantation in Shiraz,
Iran. Hepat Mon 2015;15:e26407.
148. Bahador Z, Dehghani SM, Bahador A, et al. Parents' education level and mortality
and morbidity of children after liver transplantation. Int J Organ Transplant Med
2015;6:25-30.
149. Karimi MH, Geramizadeh B, Malek-Hosseini SA. Tolerance Induction in Liver. Int
J Organ Transplant Med 2015;6:45-54.
150. Mansoorian M, Kazemi K, Nikeghbalian S, et al. Liver transplantation as a
definitive treatment for familial hypercholesterolemia: A series of 36 cases. Pediatr
Transplant 2015;19:605-11.
151. Musavi Z, Azarpira N, Sangtarash MH, et al. Polymorphism of Transcription
Factor-7-Like 2 (TCF7L2) Gene and New-Onset Diabetes after Liver
Transplantation. Int J Organ Transplant Med 2015;6:14-22.
152. Nikeghbalian S, Shamsaeefar A, Eshraghian A, et al. Liver transplantation and
whipple surgery combined with chemoradiotherapy for treatment of hilar
CURRICULUM VITAE DR. SEYED ALI MALEK HOSSEINI
ABU – ALI SINA CHARITY HOSPITAL 17
cholangiocarcinoma in patients with primary sclerosing cholangitis. Liver Transpl
2015;21:696-9.
153. Amoozgar H, Ermis R, Honar N, Malek-Hosseini SA. Myocardial Performance
after Successful Liver Transplantation. Int J Organ Transplant Med 2016;7:77-83.
154. Darban-Sarokhalil D, Khoramrooz SS, Marashifard M, et al. Molecular
characterization of Staphylococcus aureus isolates from southwest of Iran using
spa and SCCmec typing methods. Microb Pathog 2016;98:88-92.
155. Fakhar N, Nikeghbalian S, Kazemi K, et al. Transplantation of Deceased Donor
Livers With Elevated Levels of Serum Transaminases at Shiraz Transplant Center.
Hepat Mon 2016;16:e40140.
156. Khoramrooz SS, Mansouri F, Marashifard M, et al. Detection of biofilm related
genes, classical enterotoxin genes and agr typing among Staphylococcus aureus
isolated from bovine with subclinical mastitis in southwest of Iran. Microb Pathog
2016;97:45-51.
157. Khoramrooz SS, Sharifi A, Yazdanpanah M, et al. High Frequency of Class 1
Integrons in Escherichia coli Isolated From Patients With Urinary Tract Infections
in Yasuj, Iran. Iran Red Crescent Med J 2016;18:e26399.
158. Khosravi M, Saadat I, Karimi MH, Malek Hosseini SA. Association of GSTO2
(N142D) Genetic Polymorphism and Acute Rejection of Liver. Int J Organ
Transplant Med 2016;7:183-7.
159. Lankarani KB, Malek-Hosseini SA, Nikeghbalian S, et al. Fourteen Years of
Experience of Liver Transplantation for Wilson's Disease; a Report on 107 Cases
from Shiraz, Iran. PLoS One 2016;11:e0167890.
160. Masoumi SJ, Mazloom Z, Rezaianzadeh A, et al. Prevalence of Metabolic
Syndrome in Liver Transplant Recipients in Iran. Int J Organ Transplant Med
2016;7:85-90.
161. Parhizgari N, Khoramrooz SS, Malek Hosseini SA, et al. High frequency of
multidrug-resistant Staphylococcus aureus with SCCmec type III and Spa types
t037 and t631 isolated from burn patients in southwest of Iran. APMIS
2016;124:221-8.
162. Salehipour M, Kazemi K, Shamsaeefar A, et al. Nutcrackerlike Phenomenon Is An
Unusual Cause for Gross Hematuria After a Kidney Graft. Exp Clin Transplant
2016;14:93-5.
163. Yazdanpanah S, Geramizadeh B, Nikeghbalian S, Malek-Hosseini SA.
Hepatocellular Carcinoma and Its Precursors in 103 HBV-Related Cirrhotic
Explanted Livers: A Study from South Iran. Hepat Mon 2016;16:e38584.
164. Eshraghian A, Imanieh MH, Dehghani SM, et al. Post-transplant
CURRICULUM VITAE DR. SEYED ALI MALEK HOSSEINI
ABU – ALI SINA CHARITY HOSPITAL 18
lymphoproliferative disorder after liver transplantation: Incidence, long-term
survival and impact of serum tacrolimus level. World J Gastroenterol 2017;23:1224-
32.
165. Fattahi MR, Malek-Hosseini SA, Sivandzadeh GR, et al. Clinical Course of
Ulcerative Colitis After Liver Transplantation in Patients with Concomitant
Primary Sclerosing Cholangitis and Ulcerative Colitis. Inflamm Bowel Dis
2017;23:1160-7.
166. Geramizadeh B, Malek-Hosseini SA. Role of Histopathologist in Liver
Transplantation. Int J Organ Transplant Med 2017;8:1-6.
167. Kazemi K, Samidoost P, Deilami HN, et al. A New Consideration in Hepatic
Artery Reconstruction in Adult Liver Transplant: Arterial Transposition Versus
Extra-Anatomic Jump Grafts. Exp Clin Transplant 2017;15:204-7.
168. Lankarani KB, Taghavi SA, Pahlavan Sabbagh MR, Malek-Hosseini SA.
Cytomegalovirus Peritonitis Without Gut Perforation But With Concomitant
Colitis After a Liver Allograft Transplant. Exp Clin Transplant 2017;15:106-9.
169. Pouladfar G, Jafarpour Z, Firoozifar M, et al. Urinary Tract Infections Among
Hospitalized Adults in the Early Post-Liver Transplant Period: Prevalence, Risk
Factors, Causative Agents, and Microbial Susceptibility. Exp Clin Transplant
2017;15:190-3.
170. Afshari A, Yaghobi R, Azarpira N, et al. Evaluation of Interleukin-21, 23 and 27
mRNA Expression and Protein Level in Liver Transplant Patients. Iran J Allergy
Asthma Immunol 2018;17:298-307.
171. Al Sayyed MH, Shamsaeefar A, Nikeghbalian S, et al. Single Center Long-Term
Results of Pediatric Liver Transplantation. Exp Clin Transplant 2018.
172. Baghernezhad M, Mani A, Ayoobzadehshirazi A, et al. Psychologic Evaluation in
Liver Transplantation: Assessment of Psychologic Profile of End-Stage Liver
Disease Patients Before and After Transplant. Exp Clin Transplant 2018.
173. Eshraghian A, Nikeghbalian S, Geramizadeh B, Malek-Hosseini SA. Serum
magnesium concentration is independently associated with non-alcoholic fatty
liver and non-alcoholic steatohepatitis. United European Gastroenterol J 2018;6:97-
103.
174. Eshraghian A, Nikeghbalian S, Kazemi K, et al. Portal vein thrombosis in patients
with liver cirrhosis and its impact on early and long term outcomes after liver
transplantation. Int J Clin Pract 2018:e13309.
175. Hashemizadeh Z, Malek-Hosseini SA, Badiee P. Prevalence of CYP2C19 Genetic
Polymorphism among Normal People and Patients with Hepatic Diseases. Int J
Organ Transplant Med 2018;9:27-33.
CURRICULUM VITAE DR. SEYED ALI MALEK HOSSEINI
ABU – ALI SINA CHARITY HOSPITAL 19
176. K BL, Malek Hosseini SA. The Situation of Liver Transplantation Programs in Iran.
Middle East J Dig Dis 2018;10:194-5.
177. Malek-Hosseini SA, Jafarian A, Nikeghbalian S, et al. Liver Transplantation Status
in Iran: A Multi-center Report on the Main Transplant Indicators and Survival
Rates. Arch Iran Med 2018;21:275-82.
178. Marashifard M, Karimi Aliabad Z, Malek Hosseini SAA, et al. Determination of
antibiotic resistance pattern and virulence genes in Escherichia coli isolated from
bovine with subclinical mastitis in southwest of Iran. Trop Anim Health Prod 2018.
179. Mirzaii M, Jamshidi S, Zamanzadeh M, et al. Determination of gyrA and parC
mutations and prevalence of plasmid-mediated quinolone resistance genes in
Escherichia coli and Klebsiella pneumoniae isolated from patients with urinary
tract infection in Iran. J Glob Antimicrob Resist 2018;13:197-200.
180. Raza SM, Zainab S, Shamsaeefar AR, et al. Experience of Liver Transplant in
Patients Diagnosed with Budd-Chiari Syndrome. Exp Clin Transplant 2018;16:177-
81.
181. Shamsaeefar A, Saleh T, Kazemi K, et al. Retransplant of the Liver: 12-Year
Experience of the Shiraz Organs Transplantation Center. Exp Clin Transplant 2018.
182. Yaghobi R, Kazemi MJ, Geramizadeh B, et al. Significance of Occult Hepatitis C
Virus Infection in Liver Transplant Patients With Cryptogenic Cirrhosis. Exp Clin
Transplant 2018.
183. Pouladfar G, Jafarpour Z, Malek Hosseini SA, et al. Bacterial infections in pediatric
patients during early post liver transplant period: A prospective study in Iran.
Transpl Infect Dis 2019;21:e13001.